Home › Funds › Lion Point Capital, LP › KURA

Lion Point Capital, LP position in KURA

KURA ONCOLOGY INC · Health Care

Lion Point Capital, LP reported holding 46,000 shares of KURA (KURA ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$505K, representing 2.41% of its reported portfolio and ranking #18 among its reported holdings. Lion Point Capital, LP has disclosed KURA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)46.00K sh
Reported value held$504.62K
Portfolio Weight2.41%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's KURA position evolved

Lion Point Capital, LP first disclosed a stake in KURA in Q3 2025 at 46,000 shares (US$407K). The position peaked in Q2 2026 at 46,000 shares, worth US$505K. Across 4 filings, Lion Point Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 46,000 shares valued at US$505K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 46.00K $407.10K New
Q4 2025 46.00K $477.94K Hold
Q1 2026 46.00K $373.98K Hold
Q2 2026 46.00K $504.62K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KURA and 13F data

KURA (KURA ONCOLOGY INC) is a Health Care company. 27 other funds we track also report a position in KURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$94.1M), BVF INC/IL (US$92.7M), ARMISTICE CAPITAL, LLC (US$40.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KURA

All KURA fund holders →

FAQ

How long has Lion Point Capital, LP held KURA?

Lion Point Capital, LP has disclosed KURA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Lion Point Capital, LP's current position in KURA?

As of Q2 2026, Lion Point Capital, LP holds 46.00K shares of KURA (KURA ONCOLOGY INC), valued at $504.62K, representing 2.41% of its reported portfolio and ranking #18.

Has Lion Point Capital, LP been buying or selling KURA?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in KURA. The position peaked in Q2 2026 at 46.00K shares.

Which other funds hold KURA?

Other major institutional holders of KURA include MONTANOVA CAPITAL, LLC, BVF INC/IL, ARMISTICE CAPITAL, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.